Uncategorized
FDA clears Optovue’s epi-mapping software
Optovue’s epithelial thickness mapping software has become the first to be cleared by the FDA for quantitative measurements of the epithelial and stromal layers of the cornea, according to a company press release. Aiding in the diagnosis, documentation and management of ocular health and diseases, epi-mapping provides epithelial thickness information in a fast, non-contact exam, the release said. It is available through the iVue and iFusion OCT systems.